Goldman Sachs’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
Other funds holding PBH
AI
VPM
VCM
Goldman Sachs's PBH Position: Q1 2026 in Review
Goldman Sachs reduced its Prestige Consumer Healthcare (PBH) stake by 13% in Q1 2026, selling an estimated $4.48M and leaving 457,618 shares worth $27.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2150.
Goldman Sachs first reported a position in PBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $84.2M in Q2 2025. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.
- Goldman Sachs held 457,618 shares of Prestige Consumer Healthcare worth $27.1M as of Q1 2026.
- Goldman Sachs sold 69,009 Prestige Consumer Healthcare shares in Q1 2026, an estimated $4.48M.
- Prestige Consumer Healthcare made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2150 holding.
- Goldman Sachs first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Prestige Consumer Healthcare position peaked at $84.2M in Q2 2025.
- 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.